Researcher
Kathelijne Peerlinck
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → 30 Sep 2021
Projects
1 - 4 of 4
- Genome medicine for bleeding, thrombotic and platelet disordersFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
- Quantification of joint loading in adults with haemophilia using multi-segment foot modellingFrom1 Mar 2018 → 8 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Biomechanische determinanten en patronen geassocieerd aan de pathophysiologische enkelarthropathie cascade van kinderen met haemophilie.From1 Oct 2014 → 30 Sep 2016Funding: BOF - Other initiatives
- (Epi)Genetic studies and system biology approaches to characterize rare inherited bleeding and platelet disorders: from patient studies to basic biology to cl inical applicationsFrom1 Oct 2014 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 108
- Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1(2023)
Authors: Kathelijne Peerlinck
Pages: 3450 - 3462 - Emicizumab for acquired haemophilia A: A case series(2023)
Authors: Veerle Labarque, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche
Pages: 1049 - 1055 - Ribosome dysfunction underlies SLFN14-related thrombocytopenia(2023)
Authors: Fabienne Ver Donck, Kato Ramaekers, Kathelijne Peerlinck, Chris Van Geet, Veerle Labarque, Kathleen Freson
Pages: 2261 - 2274 - Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience(2023)
Authors: Veerle Labarque, Thomas Vanassche, Chris Van Geet, Peter Verhamme, Kathelijne Peerlinck, Kathleen Freson
Pages: 887 - 895 - Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B(2023)
Authors: Kathelijne Peerlinck
Pages: 706 - 718 - Methylome analysis for haemophilia A intron 22 inversion patients with and without inhibitors: A pilot study(2022)
Authors: Veerle Labarque, Chris Van Geet, Kathelijne Peerlinck, Kathleen Freson
Pages: E248 - E250 - F11 Gene Duplication Causes Elevated FXI Plasma Levels and Is a Risk for Venous Thrombosis(2022)
Authors: Kathelijne Peerlinck, Marc Jacquemin, Veerle Labarque, Kathleen Freson
Pages: 1 - 3 - Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A(2022)
Authors: Kathelijne Peerlinck
Pages: 1013 - 1025 - Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing(2022)
Authors: Christophe Vandenbriele, Caroline Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Dauwe, et al.
- Coagulation Factors Accumulate During Normothermic Liver Machine Perfusion Regardless of Donor Type and Severity of Ischemic Injury(2022)
Authors: Nicholas Gilbo, Marc Jacquemin, Louis Libbrecht, Kathelijne Peerlinck, Jacques Pirenne, Diethard Monbaliu, Ina Jochmans
Pages: 510 - 518